Advertisement

Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models

Keina M.C. Dourado, June Baik, Vanessa K.P. Oliveira, Miriam Beltrame, Ami Yamamoto, Charles P. Theuer, Camila A.V. Figueiredo, Michael R. Verneris and Rita C.R. Perlingeiro

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted January 19, 2017
  • Accepted March 20, 2017
  • Published online March 31, 2017.

Article Versions


Contributors 
  • Keina M.C. Dourado, 1 Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, United States;
  • June Baik, 1 Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, United States;
  • Vanessa K.P. Oliveira, 1 Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, United States;
  • Miriam Beltrame, 2 Laboratory for the Diagnosis of Onco-Hematological Disorders, Curitiba, Brazil;
  • Ami Yamamoto, 1 Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, United States;
  • Charles P. Theuer, 3 TRACON Pharmaceuticals, Inc., San Diego, CA, United States;
  • Camila A.V. Figueiredo, 4 Instituto de Ciencias da Saude, Federal University of Bahia, Salvador, Brazil;
  • Michael R. Verneris, 5 Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States
  • Rita C.R. Perlingeiro, 1 Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output